Semax vs Selank: A Research Comparison

Semax and Selank are short synthetic peptides, each seven amino acids long. They come from the same Russian neuropeptide research program. That is why they are so often discussed together. Yet their sequences, parent molecules, and the signaling systems they probe are distinct. This article compares Semax vs Selank strictly as lab research materials. All findings come from in vitro assays and animal models.

How are Semax and Selank related?

Semax and Selank share a research lineage and a design strategy, but not a parent molecule. Both were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Both are stabilized analogs of natural regulatory peptides.

The design strategy was the same for each. Start with a short natural sequence with known biological activity. Then add a Pro-Gly-Pro motif to the end of the chain. The literature links this motif to resistance against enzyme breakdown. This shared approach is why the two are so often named together.

The starting materials are unrelated. Semax is built on the ACTH(4-10) fragment of adrenocorticotropic hormone. Selank is built on tuftsin, a natural four-amino-acid peptide that affects the immune system. One lineage starts in hormone signaling. The other starts in immune signaling. That split carries through to the research models each one is used in.

For study design, a short summary helps. Semax is studied mostly around the expression of neurotrophic factors, the proteins that support nerve cells. Selank is studied around inhibitory neurotransmission and neuroimmune signals.

Neither has a single defined receptor target in the published literature. So both are best seen as multi-system tool compounds, not selective probes.

How do their sequences and specifications compare?

The two peptides are similar in size but differ a great deal in makeup.

Semax specs:

• Sequence: Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)
• Molecular formula: C37H51N9O10S
• Molecular weight: about 813.93 g/mol
• CAS number: 80714-61-0

A sulfur-containing methionine at the start and an aromatic phenylalanine set Semax apart structurally.

Selank specs:

• Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP)
• Molecular formula: C33H57N11O9
• Molecular weight: about 751.88 g/mol
• CAS number: 129954-34-3
• Also listed as TP-7

Selank is basic and very polar compared with Semax. This reflects the lysine and arginine it takes from the tuftsin core.

• Shared feature: a Pro-Gly-Pro extension at the end of the chain, linked in the literature to slower breakdown. For Selank, it is tied to less cutting by carboxypeptidase and prolyl endopeptidase.
• Semax change: the native Arg-Trp-Gly end of ACTH is replaced. This is reported to remove its hormone-releasing activity while keeping its activity on nerve tissue.
• Format: both come as white freeze-dried powder in sealed 10mg glass vials, verified to at least 99% purity.

How is Semax studied in neurotrophic signaling?

The most consistent finding for Semax involves BDNF and its receptor, TrkB. BDNF stands for brain-derived neurotrophic factor.

In rat hippocampus models, single applications of Semax have been reported to raise BDNF protein and mRNA levels. They have also been reported to raise TrkB phosphorylation. Labs use those endpoints to describe neurotrophic signaling.

Comparative work has also tracked how NGF and BDNF gene expression change over time. These studies looked at the hippocampus, frontal cortex, and retina under Semax exposure.

Beyond these factors, Semax appears in models of reduced blood flow and low oxygen in the brain. There it is used to study cell survival, gene expression, and neurotrophic signal levels. It also appears in learning and memory paradigms.

The removal of hormone-releasing activity is central to its value as a tool. It lets labs separate the nerve-related behavior of the ACTH fragment from the hormonal actions of the parent molecule. The Semax mechanism of action article breaks these steps down further.

How is Selank studied in GABA and neuroimmune signaling?

Selank research runs along a different line. A main focus is its effect on GABA signaling, the brain's main inhibitory system. In cell models, Selank has been reported to change the expression of genes involved in GABA signaling.

Labs use it to probe how tuftsin-derived peptides interact with inhibitory neurotransmitter systems. That is a very different question from the neurotrophin question that dominates Semax research.

Selank comes from tuftsin, so it also has an immune side that Semax lacks. It has a reported influence on cytokine and interferon pathways. That makes it a recurring subject in neuroimmune research, including immune cell activity in controlled models.

In behavioral work, it appears in anxiety-related models. Labs note that it lacks the sedative profile of classic benzodiazepine tool compounds. That suits designs comparing peptides in anxiety models.

The Selank mechanism of action article covers the multi-system detail.

How should a lab choose between Semax and Selank?

The endpoint usually decides, not relative potency.

• Semax matches panels built on neurotrophin transcript and protein levels, TrkB phosphorylation, or cell survival after low blood flow or low oxygen.
• Selank matches panels built on GABA-related gene expression, monoamine turnover, cytokine profiles, or anxiety-type behavioral endpoints.

Real overlap exists in two places. Both are studied for effects on monoamine systems. Both also feature in structure-activity and stability work on Pro-Gly-Pro stabilized peptides.

Labs studying enzyme resistance or brain entry as design traits often run the pair side by side. The reason is simple. They share the stabilizing motif but differ in everything else.

Why are Semax and Selank sometimes studied as a pair?

Running both in one series lets a lab ask whether an effect tracks the shared motif or the distinct parent sequence. That is a common reason for parallel-arm designs.

It is also why the Selank/Semax blend exists. It is a single-vial format for teams that want both peptides on hand in one study.

Whether mixing them in one batch is suitable depends on the model and the controls. It also depends on whether the design can credit an effect to either component.

Labs running them together should plan single-compound control arms. Without them, a mixed batch cannot separate a Semax-linked neurotrophic signal from a Selank-linked GABA or immune signal.

How are Semax and Selank sourced and handled?

Puritide Research supplies both peptides as freeze-dried research-use-only material. They are sourced from qualified synthesis partners and checked by independent third-party labs.

Every batch ships with a certificate of analysis. It records purity by HPLC, identity by mass spectrometry, lot number, test date, and method. Sample certificates are available before purchase, and independent checks are encouraged.

Storage guidance is the same for both:

• Keep sealed at or below 25 degrees Celsius.
• Keep away from heat, light, and moisture.
• For long storage, keep the material freeze-dried and chilled or frozen.

Standard lab practice applies throughout. Follow institutional procedures and wear suitable protective gear. Split material into aliquots to limit freeze-thaw cycles. Record lot numbers so results stay traceable across a study.

Common research questions

Are Semax and Selank interchangeable in a study design?

No. They come from different parent sequences, one from the ACTH(4-10) fragment and one from tuftsin. The published models differ to match. Swapping one for the other changes which signaling system the experiment actually tests.

What do the two peptides genuinely have in common?

Both are synthetic seven-amino-acid peptides from the same Russian institute. Both extend a shorter natural regulatory peptide with a Pro-Gly-Pro end motif linked to enzyme stability. Both are studied as multi-system tool compounds, not selective receptor ligands.

Is either compound approved for use outside the laboratory?

No. Both remain research compounds in most of the world. Puritide Research supplies them only as lab materials, not for human or veterinary application. The findings above come from in vitro assays and animal models and should be read in that context.

For research use only. Semax and Selank are laboratory research compounds. They are not for human or veterinary use, diagnostic use, or any therapeutic application.